Invesco’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$595K Buy
303,507
+116,973
+63% +$274K ﹤0.01% 3092
2025
Q4
$506K Buy
186,534
+61,193
+49% +$201K ﹤0.01% 3193
2025
Q3
$530K Buy
125,341
+38,530
+44% +$169K ﹤0.01% 3210
2025
Q2
$432K Buy
86,811
+20,735
+31% +$90.1K ﹤0.01% 3224
2025
Q1
$291K Buy
66,076
+31,617
+92% +$148K ﹤0.01% 3366
2024
Q4
$160K Sell
34,459
-722
-2% -$3.97K ﹤0.01% 3552
2024
Q3
$244K Sell
35,181
-114,766
-77% -$901K ﹤0.01% 3473
2024
Q2
$1.17M Buy
149,947
+122,975
+456% +$911K ﹤0.01% 2855
2024
Q1
$192K Sell
26,972
-2,833
-10% -$18.7K ﹤0.01% 3659
2023
Q4
$200K Buy
29,805
+5,087
+21% +$28.6K ﹤0.01% 3571
2023
Q3
$139K Sell
24,718
-158,891
-87% -$1.06M ﹤0.01% 3675
2023
Q2
$1.01M Buy
183,609
+159,501
+662% +$858K ﹤0.01% 2891
2023
Q1
$151K Sell
24,108
-8,714
-27% -$48.6K ﹤0.01% 3663
2022
Q4
$153K Buy
32,822
+1,766
+6% +$8.7K ﹤0.01% 3758
2022
Q3
$145K Sell
31,056
-71
-0.2% -$448 ﹤0.01% 3761
2022
Q2
$184K Buy
31,127
+11,215
+56% +$125K ﹤0.01% 3751
2022
Q1
$385K Buy
+19,912
New +$457K ﹤0.01% 3525
2021
Q3
Sell
-94,043
Closed -$3.39M 4034
2021
Q2
$3.39M Sell
94,043
-1,460,133
-94% -$53.9M ﹤0.01% 2615
2021
Q1
$60.6M Sell
1,554,176
-579,842
-27% -$26.1M 0.02% 979
2020
Q4
$86.1M Buy
2,134,018
+1,186,610
+125% +$54.5M 0.03% 802
2020
Q3
$52.7M Buy
+947,408
New +$50.2M 0.02% 920

Other funds holding GDRX

Invesco's GDRX Position: Q1 2026 in Review

Invesco increased its GoodRx Holdings (GDRX) stake by 63% in Q1 2026, buying an estimated $274K and bringing the position to 303,507 shares worth $595K. The position accounts for ﹤0.01% of the portfolio, ranked #3092.

Invesco first reported a position in GDRX in Q3 2020 and has held it in 21 quarters since. The position peaked at $86.1M in Q4 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Invesco held 303,507 shares of GoodRx Holdings worth $595K as of Q1 2026.
  • Invesco bought 116,973 GoodRx Holdings shares in Q1 2026, an estimated $274K.
  • GoodRx Holdings made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3092 holding.
  • Invesco first reported a position in GoodRx Holdings in Q3 2020 and has held it in 21 quarters since.
  • Invesco's GoodRx Holdings position peaked at $86.1M in Q4 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.